Latest "Altus Capital Partners, Inc." News Stories - Page: 3

17:31 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "Altus Capital Partners, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Altus Capital Partners, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Altus Capital Partners, Inc. for you to read. Along with our medical data and news we also list Altus Capital Partners, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Altus Capital Partners, Inc. Companies for you to search.

Showing "Altus Capital Partners" News Articles 51–75 of 6,600+

Monday 25th March 2019

PreveCeutical Announces Default Judgment Against Essos Corporate Services Inc. and Detona Capital Corp.

PreveCeutical Medical Inc. (CSE:PREV, OTC:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), announces that it has obtained a default judgement against each of Essos Corporate Services Inc. ("Essos") and Detona Capital Corp. ("Detona") in connection with a Supreme Court of British Columbia action (the "Action"). The post PreveCeutical Announces Default Judgment Against Essos Corporate Services In...

Nexstim Plc: Decisions of the Board of Directors regarding Board Committees and issuance of shares under the restricted share unit plan

Company announcement, Helsinki, 25 March 2019, at 2 PM  Nexstim Plc: Decisions of the Board of Directors regarding Board Committees and issuance of shares under the restricted share unit plan Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive ...

Charles G. Berg Joins Turn-Key Health Board of Directors: Executive Leader at DaVita Medical Group, WellCare, UnitedHealth and Oxford

Turn-Key Health (Turn-Key), an Enclara Healthcare company, serving health plans, provider organizations and their members who experience a serious or advanced illness, welcomes Charles “Chuck” Berg, a veteran healthcare executive who has served in various leadership roles throughout the industry, to its board of directors. Currently, he is on the ...

Rite Aid Kicks Off 25th Annual Miracle Balloon Campaign to Support Children’s Miracle Network Hospitals

Customers Can Support Their Local Children's Hospital by Purchasing $1 Paper Miracle Balloons Rite Aid is celebrating a quarter century of miracles by hosting its 25th annual Miracle Balloon campaign for Children's Miracle Network Hospitals. Now through May 11, customers can donate to their local children’s hospital by purchasing a $1 Miracle Ba...

Curis Gets $65.0 Mln Upfront Payment On Sale Of Portion Of Erivedge Royalties

WASHINGTON (dpa-AFX) - Curis, Inc. (CRIS) announced that it has entered into an agreement with funds managed by Oberland Capital Management, LLC for up to $135.7 million in exchange for selling ri...

Bone Biologics Receives Human Research Ethics Committee (HREC) Approval for the First Center of a Multicenter Pilot Clinical Trial to Evaluate NB1 (NELL-1/DBX®) in Australia

Bone Biologics Corp. (OTCQB:BBLG), a developer of orthobiologic products for domestic and international spine fusion markets, today has announced that it received Human Research Ethics Committee (HREC) approval on March 20, 2019, for the first center of a multicenter pilot clinical trial to evaluate NB1 (NELL-1/DBX®) in 30 patients in Australia. The ...

Flare Capital Partners Appoints Parth Desai as Senior Associate

Expands Investment Team to Reinvent the Business of Healthcare Flare Capital Partners, a leading healthcare technology venture capital firm, today announced the addition of healthcare technology investor and experienced policy professional Parth Desai as a Senior Associate. “Parth has dedicated his

Arch Oncology Raises $50 Million Series B Financing

-- Financing to Advance Lead Anti-CD47 Antibody AO-176 in Ongoing Phase 1 Clinical Trial and Pipeline -- Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on the discovery and development of best-in-class anti-CD47 antibody therapies, today announced a successful $50 million Series B financing. The Company plans to use the proceeds ...

Saama Closes $40 Million Financing with Perceptive Advisors to Drive Disruption in Clinical Analytics and Drug Development

Saama Technologies, Inc. (“Saama”), a leading clinical data analytics platform firm, announced that it has closed a $40 million financing with Perceptive Advisors. The new funding will be used to support the expansion of Saama’s Life Science Analytics Cloud (LSAC), an AI-powered platform disrupting the planning, designing and conduct of clinical tria...

Appili Therapeutics Announces Closing of $3.6 Million Special Warrant Private Placement and Filing of Preliminary Prospectus

NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES. Appili Therapeutics Inc. ("Appili" or the "Company") is pleased to announce the closing of its private placement offering (the "Brokered Offering") of special warrants (the "Special Warrants") for aggregate gross proceed...

Enterprise Therapeutics strengthens leadership team, appoints Amit D. Munshi as Non-Executive Chairman

Appointment brings significant commercial pharma experience as Enterprise Therapeutics’ two lead respiratory programmes are progressed towards the clinic Brighton, UK, 25 March 2019: Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering with respiratory disease, tod...

NetScientific soars as it sells stakes in Vortex Biosciences and Wanda for £150,000

The group said after the close on 22 March that it would use the proceeds of the sale towards its ongoing working capital requirements

PreveCeutical gets default judgement in part of civil claim

Preveceutical said it had received a default judgment against Essos Corporate Services Inc and Detona Capital

Africa's legal cannabis market could generate $7.1 billion each year by 2023

Africa’s legal cannabis market could generate more than $7.1 billion each year by 2023, according to a report from market intelligence firm Prohibition Partners. Cannabis has been cultivated and consumed on the African continent for hundreds of years. However the drug remains illegal across large swathes of the continent, despite being widely cultivated and consumed. read more

Fuse Medical Reports Full Year 2018 Financial Results with Record Earnings

Fuse Medical, Inc., (OTCPINK: FZMD), an emerging manufacturer and distributor of medical devices for the orthopedic and spine marketplace, announced record earnings for the fiscal year ended December 31, 2018. Fuse filed its annual report on Form 10-K with the Securities and Exchange Commission on Thursday, March 21, 2019. 2018 Financial Highlight...

Oak Street Health Partners With Lyft in Indianapolis to Improve Access to Healthcare

INDIANAPOLIS (PRWEB) March 25, 2019 Oak Street Health , a network of centers that provide innovative primary care services to Medicare recipients, has partnered with Lyft to improve access to healthcare in Indianapolis. This partnership combines Lyft’s mission to improve people’s lives with...

Integrated Dermatology Enters New York

Christine Finnin, M.D. Joins Integrated Dermatology in Latham, N.Y. Integrated Dermatology, the largest independent dermatology practice in the United States, is opening its first location in New York with the addition of Latham Dermatology. Dr. Christine Finnin will lead the medical team at Latham Dermatology as a full-time clinician and medical direc...

Goodman Magic Mile Charity Ramp Run 2019 raises over HK$1.27 million for The Fred Hollows Foundation to help reduce blindness

HONG KONG, March 25, 2019 /PRNewswire/ -- Goodman Group and its partner sponsors are greatly contributing to reducing blindness in rural China by raising over HK$1.27 million for The Fred Hollows Foundation at the  8th Goodman Interlink Magic Mile Charity Ramp Run held on March 24. More than 650 participants took part in a variety of races up the 15-floor cargo ramp at the flagship Goodman ...

Synerkine Pharma Raises EUR3.3 Million in Series A Financing

Proceeds to build pipeline of novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain Synerkine Pharma B.V., which develops fusion proteins for the treatment of chronic pain, announced today that it successfully closed a EUR 3.3 million Series A financing from Thuja Capital, an undisclosed private investor, and the ...

Thermo Fisher Scientific to buy viral vector CDMO Brammer Bio for $1.7bn

Owned by Ampersand Capital Partners, Brammer Bio is engaged in the clinical and commercial supply of vectors for in vivo gene therapy and ex vivo gene-modified cell therapy. The post Thermo Fisher Scientific to buy viral vector CDMO Brammer Bio for $1.7bn appeared first on Pharmaceutical Business review.

NetScientific sells stakes in Vortex Biosciences and Wanda for £150,000

The group said after the close on 22 March that it would use the proceeds of the sale towards its ongoing working capital requirements

HitGen and Almirall Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration

HitGen Ltd announced that the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest. In this collaboration, HitGen will apply its advanced technology platform, based on DNA-encoded library design, synthesis and screening, to discover novel leads for Almirall. Under the terms of the ag...

Abcam Collaborates with Visikol to Develop New Tools for Improved Tissue Clearing and 3D Imaging

To improve the utility and ease-of-use of its tissue clearing products for 3D imaging, Visikol has partnered with Abcam to launch applications specific kits that allow any researcher to easily and quickly adopt tissue clearing. WHITEHOUSE, N.J. (PRWEB) March 25, 2019 Abcam, a global innovator in life science reagents and tools, and Visikol, a contract research organisation focused on advancing dr...

Dr. Man Q. Le Joins Physician Partners of America in New Boca Raton, FL Clinic

PALM HARBOR, Fla. (PRWEB) March 25, 2019 As part of its rapid expansion into new territory and laser spine pain treatments, Tampa, Fla.-based Physician Partners of America is adding a new specialist and pain clinic in South Florida. Man Q. Le, M.D., has begun performing laser spine proc...

Sunday 24th March 2019

Uncovering the secrets of the American 'Jurassic Mile'

(University of Manchester) Scientists at The University of Manchester have joined forces with a major US Museum and European partners to explore an extraordinary Jurassic dinosaur site in the badlands of Wyoming, USA.

Quick Search


News Quicklinks